Drug intelligence / Profile preview

Hearticellgram-AMI

Development stage: Phase 3
Lead developer: Pharmicell
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intra-arterial

Overview

Hearticellgram-AMI is an autologous cell therapy product composed of mesenchymal stem cells (MSCs) harvested from a patient's own bone marrow. It is indicated for the improvement of left ventricular ejection fraction in patients with acute myocardial infarction (AMI) following reperfusion. The therapy works by promoting myocardial regeneration, reducing fibrosis, and stimulating angiogenesis through the secretion of various paracrine factors. Developed by the South Korean company Pharmicell, it received landmark approval from the Korean Ministry of Food and Drug Safety in July 2011, becoming the first stem cell drug to be commercialized globally. The treatment involves isolating MSCs from bone marrow, expanding them ex vivo, and then administering them via intracoronary injection.

Brand names: Hearticellgram-AMI
Other names: Autologous bone marrow-derived mesenchymal stem cellsPharmicell-AMI

Beyond the preview

Go deeper on Hearticellgram-AMI.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hearticellgram-AMI.

Explore the full profile